Cyclacel Pharmaceuticals Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialisation of novel, mechanism-targeted drugs to treat human cancers and other serious disorders.Founded in 1996 by Professor Sir David Lane, a world leader in tumour-suppressor biology, Cyclacel's aim was to build commercially on Professor Lane's discovery of the P53 ("tumour-suppressor") gene.Today Cyclacel continues to apply its core strength in cell cycle biology. The Company is advancing a pipeline of small molecule drugs designed to stop uncontrolled cell division. There are currently two clinical stage compounds in the Cyclacel pipeline, with a third one in late preclinical development.Their corporate strategy is to advance the company's oncology pipeline internally and develop non-oncology indications through collaborations. The Company plans to retain rights to its oncology programs through Phase Ibis development before considering partnering.

Vascular Flow Technologies is focussed on the research & development of vascular and endovascular devices with the application of Spiral Laminar Flow™ Technology and forging strategic partnerships with leading industry players.VFT has evolved into an ISO 13485 Medical Device Development company with unique insight and capabilities in pre-clinical development and testing.

Tayside Medical Science Centre (TASC) brings together, within a single organisational framework, the existing functions of the Clinical Research Centre, the Tayside Clinical Trials Unit, the Tissue Bank, and the joint functions of the NHS Research & Development office and the University's Research & Innovation Services (in relation to clinical research). This strategic alignment will bring greater efficiency to research management and governance across the University and NHS.TASC provides clinical research support services for local researchers and industry partners. 

Onorach® Clinical manage Phase I to IV clinical research studies for drug products (including biologicals (stem cells)) and medical devices using a tailored partnership approach that provides an effective and efficient route for clients and patients to benefit from the potential of their products.Onorach is headquartered in the UK, with a subsidiary (Onorach Baltics) in Latvia and a newly formed subsidiary called Onorach Innovation which is focused on using technology to improve the clinical trial process.Onorach provide clinical trial solutions to pharma companies (from emerging, virtual and SMEs to large-scale multinationals) in over 26 countries.

The freshwater fisheries activities of the Scottish Government are the responsibility of the Marine Scotland Freshwater Fisheries Laboratory (FFL), Pitlochry, on the shores of Loch Faskally in Perthshire.The principal task of the FFL is to provide scientific advice to the Scottish Government on all aspects of the Scottish fisheries for migratory and fresh water species. Work on salmon and sea trout forms the bulk of the research programme, because of the high value of these species and their heavy requirements for stock management advice.

Entrust People is a privately owned resourcing consultancy headquartered in the North East of Scotland with offices across the UK, which has combined 24 years of experience in human resource provisioning and resource planning.Entrust Clinical People focuses on the convergence between science and technology with a specialisation in resourcing for Clinical research, bioinformatics, biotechnology and medical technology. This is the first dedicated resourcing service of this kind in Scotland.

Dundee Cancer Centre provides a hub to facilitate collaboration and communication of cancer-related activities funded by Cancer Research UK and others across the University of Dundee, NHS Tayside and partner organisations.Through targeted support for training and translational research, the DCC harnesses world-leading cancer research and clinical practice, promotes health equity, and supports more rapid transformation of research outcomes into the prevention, diagnosis and treatment of cancer for the local community and beyond, both nationally and internationally.

We are a core DNA sequencing and fragment analysis facility based within the Medical Research Council Protein Phosphorylation Unit in the School of Life Sciences and serving laboratories within the University of Dundee and elsewhere within the UK and EU. We are located within dedicated laboratory space that forms part of the School of Life Sciences on the main campus. The revenue brought in by the work we do covers the running costs of the facility. Any additional revenue is used to help fund the academic research of our parent laboratories. This involves research into diseases such as diabetes, cancer, arthritis and Alzheimers disease. Although we are part of the MRC Unit, the facility is managed as an independent entity and we ensure strict confidentiality is maintained with regard to customer samples and results, so confidentiality can be assured. We provide a wide range of contract research products for DNA analysis and associated services. We are also willing to discuss custom projects. Please contact us to  discuss your individual requirements and how we might assist you.

The CIRCA team was founded by a multi-disciplinary group of academics and researchers from the universities of Dundee and St Andrews who came together overten years ago to explore ways in which computer-based technologies could help support people living with dementia.

The University of Dundee has an international research reputation in the field of biomedical lifesciences and attracts over £50 million per annum in research funding, 90% of which is directed to the biomedical area. All life science and clinical research departments are 5/5*, the highest rating available. The University has established several multi-million pound research collaborations with the pharmaceutical industry in the areas of drug discovery, pharmacogenomics and translational medicine.Key areas of research at the University include Cancer, Diabetes, Cardiovascular Disease, Respiratory Diseases, Gene Regulation and Expression, Genomics, GutBiology, Immunology, Neurosciences, Kinase/Research & Signal Transduction. The University also has expertise in Biomedical Engineering, Medical Devices and is a centre of Health Informatics Pharmacogenomics Tissue Engineering expertise.